Physician profile
Christopher L Cole
NPI 1457312001
$5,331.22
in general payments reported to CMS, 2019-2025
38 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $72.92 · 2021: $504 · 2022: $282 · 2023: $243 · 2024: $3,651 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $1,187 · Travel and Lodging: $423 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $1,186.52 |
| Travel and Lodging | $423.39 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,500.00 | 2024 | |
| Intuitive Surgical, INC. | $1,346.54 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $220.75 | 2019-2023 | Vistaseal, Stratafix, Echelon; Endopath |
| Davol INC. | $158.56 | 2021-2023 | Phasix Mesh |
| Pylant Medical | $146.28 | 2025 | |
| Allergan, INC. | $122.22 | 2019 | |
| Polynovo North America LLC | $76.52 | 2023-2024 | Novosorb Btm |
| Baudax Bio INC. | $61.79 | 2021-2022 | |
| Teleflex LLC | $49.54 | 2021-2025 | Weck, Quikclot |
| Merck Sharp & Dohme LLC | $45.46 | 2019-2020 | |
| Acacia Pharma INC | $36.82 | 2021 | |
| W. L. Gore & Associates, INC. | $34.40 | 2021 | |
| Redhill Biopharma INC. | $33.83 | 2021 | |
| Vivus LLC | $31.69 | 2021-2022 | |
| Boston Scientific Corporation | $29.25 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $26.09 | 2024 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $24.92 | 2023 | Zynrelef |
| Ambu INC. | $24.76 | 2022 | |
| Nestle Healthcare Nutrition INC. | $23.43 | 2020 | |
| Organogenesis INC. | $23.40 | 2022 | |
| Stryker Corporation | $23.24 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.28 | 2025 | |
| Innocoll Pharmaceuticals Limited | $21.36 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $20.18 | 2019 | |
| Kci USA, INC. | $19.45 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.17 | 2019 | |
| Abbvie INC. | $18.91 | 2025 | |
| Daiichi Sankyo INC. | $18.36 | 2022 | |
| Conmed Corporation | $18.22 | 2025 | Airseal |
| Coopersurgical, INC. | $17.86 | 2024 | Insorb |
| Innovation Technologies INC | $16.77 | 2022 | |
| Shire North American Group INC | $16.42 | 2019 | |
| Angiodynamics, INC. | $16.31 | 2023 | Smart Port Ct |
| Currax Pharmaceuticals LLC | $14.69 | 2023 | Contrave |
| Takeda Pharmaceuticals U.S.A., INC. | $14.47 | 2023 | Gattex |
| Braintree Laboratories, INC. | $13.79 | 2019 | |
| Smith+Nephew, INC. | $12.39 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.